Esomeprazole and omeprazole may well enhance the serum concentrations of benzodiazepines (by way of CYP2C19 inhibition) resulting in enhanced adverse effects for instance drowsiness, although the clinical relevance is low for most clients – watch the client for adverse effects (e.If affected individual can not resume their regular oral medication